时间:2024-12-23
Dan Liu,Lin-Mei Sun,Jing-Hua Liang, Lei Song,Xiao-Pei Liu
Abstract
Key Words: ≥ 16-detector CT; Diagnostic; Colon cancer; Systematic review; Meta-analysis
One of the most common cancers in the world is colorectal cancer[1-3], for which an update on the incidence is provided every 3 years by the American Cancer Society from population-based cancer registrations (as of 2016) and mortality data from the National Center for Health Statistics (as of 2017). These data indicate that colorectal cancer is the third most commonly seen cancer and the third leading cause of cancer death, with the prediction of approximately 147950 new cases of colorectal cancer diagnosed and 53200 deaths recorded by the year 2020[4]. The average annual incidence of colorectal cancer in men and that in women in the United States from 2011 to 2015 were also disclosed to be 45.9/100000 and 34.6/100000, respectively[5]. Classified by the World Health Organization as a single entity, colon cancer and rectal cancer are largely different in their diagnoses, treatments, surgical methods, and recurrence rates[6,7]. The early symptoms of colon cancer patients, such as hematoma, diarrhea, changes in bowel habits, local abdominal pain, and anemia, are easy to ignore, thus leading to approximately 20% of late-stage patients missing the best treatment time over the past 20 years[8]. Characterized by noninvasiveness, high sensitivity and specificity, safety, availability, convenience, and inexpensiveness, a full colonoscopy is the "ideal" screening test for colon cancer, as recommended by the guidelines, and involves varying measurements and strategies with advantages and disadvantages, but is well tolerated, especially under adequate sedation[9]. Full colonoscopy has been shown by a literature review to have a high sensitivity (96%-97%) and specificity (98%), with, aside from other high risks, a perforation rate of 0.1%, bleeding risk of greater than 0.3%, and mortality rate of 0.01%-0.03%[10,11]. Computed tomography (CT) colonography is highly sensitive and cost-effective in detecting colon cancer, and is a technique that applies the optimal bowel wall dilation 3D colon reconstruction (to create a virtual colonoscopy). Elias Neradet al[12] demonstrated that such an analysis had an excellent sensitivity in detecting colorectal T3-T4, with the CT digits not screened, due to the low lymph node metastasis resulting from the challenge of distinguishing between T1-T3Ab and T3CD-T4. In recent years,≥ 16-slice spiral computed tomography (SCT) have been mostly applied to detect the local stage of colon cancer. This meta-analysis was designed to specifically determine the diagnostic accuracy of ≥ 16-slice SCT used only for colon cancer staging, thus assessing whether ≥ 16-slice SCT is conducive to distinguishing between high-risk and low-risk colon cancer.
PubMed, EMBASE, Cochrane Library, and Web of Science were searched with computers from the establishment of the database to April 2021, with terms such as "colon cancer", "colon tumor", "colorectal cancer", "tumor staging", "computed tomography", and "CT" serving as keywords.
After deleting duplicate publications, reasonable inclusion criteria and exclusion criteria were developed to review the remaining studies. The inclusion criteria were: (1) The purpose of the study was the diagnostic value of computed tomography in the diagnosis of colon cancer; (2) The experimental design was prospective or retrospective; and (3) The inclusion criteria were symptoms, signs, or laboratory tests of colon cancer, with histopathological results serving as the standard for diagnosis of cancer.
The exclusion criteria were: (1) Reviews, case reports, editorials, correspondences, comments, or meeting abstracts/meeting minutes; (2) The number of CT slices was not described in the study and could not be determined, by other means, whether it was ≥ 16-slice CT or < 16-slice CT; (3) Studies without available diagnostic results in a two-by-two table; (4) Studies in languages other than English; and (5) Studies without available full texts.
The data from the literature were independently extracted by two researchers, and were put into a predrawn data table as follows: (1) Basic research information, including the first author, the publication year, the country from which the first author comes, the test time, and the type of the research design; (2) The characteristics of the tested population, including the patients’ age, gender, the number of participants, and the pathological stage; (3) The CT slices; (4) The details of reference standards; (5) The research results, including the number of true positives, false positives, false negatives, and true negatives, for the purpose of determining the accuracy of the diagnoses; and (6) Reference Citation Analysis (https://www.referencecitationanalysis.com/).
The methodological quality of the included studies was assessed by two researchers on the basis of the Quality Evaluation Checklist of the Canadian Institute of Economics (IHE)[13], then cross-checked, and finally an agreement was reached. In light of the misleading scoring of the item conformity[14], the scoring method was not included in the quality evaluation checklist of the IHE methodological case series, and corresponding options for each item were provided instead, leading to the assessment of 13 case series based on the final list. Studies were recommended as acceptable with 14 (70%) or more items in conformity despite the fact that a corresponding quality assessment system had not yet been formulated by the expert group.
The data were analyzed with Meta-disc 14.0 and Stata 15.0. The threshold effect was determined with Meta-disc 14.0. All of the heterogeneity degrees were assessed by the heterogeneity index (I²). The random effects model was adopted in the case ofI² > 50%. Conversely, the fixed effects model was applied for the purpose of analyzing indicators such as sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio (DOR,) and area under the curve (AUC). The publication bias of the included literature (≥ 10 articles) was examined by Deeks' test on Stata 15.0.
With 663 articles left after deleting duplicates from 751 preliminarily retrieved original articles, a fulltext analysis was performed on the basis of the 58 articles remaining after screening by titles and abstracts, leaving 47 articles excluded with full-texts of 14 articles not available, 3 articles without TMN staging descriptions, and 30 articles with different detection methods, resulting in 11 articles finally included in this study (Figure 1)[15-25].
Figure 1 Literature search and results.
The basic characteristics of the literature included in this study are shown in Table 1-4. A total of 1613 participants were included in the 11 studies, of which three[15,17,24] were on colorectal cancer while the remaining 8[16,18-23,25] were on colon cancer, with 5 of the 11 studies[15,17,18,20] performed with 16-slice CT, 6[16,21-25] with 64-slice CT, and 1[19] with 16-slice (Siemens SOMATON Sensation 16) or 64-slice CT (GE LightSpeed VCT). Four of the eleven [15,20,23,25] were performed as retrospective studies and the remaining 7[16-19,21,22,24] as prospective studies; only 2[19,24] were performed for the followup. In terms of the display of diagnostic results, 11 studies showed the diagnostic results of the T staging of colon cancer, among which Rollvénet al[16] reached different judgments on the CT diagnosis results, thus leading to ultimate disagreement, and 4 studies[15,17,19,23] showed the diagnostic results of N staging. With the methodological quality assessment conducted by the IHE quality assessment checklist, the assessment results showed that all 11 included studies met the requirement of more than 14 items (70%), indicating that the quality of the literature included in this study was acceptable.
Heterogeneity of meta-analysis of T staging:In a diagnostic meta-analysis, heterogeneity is primarily generated by threshold and nonthreshold effects. In this study, there was no "shoulder-arm" distribution in the "ROC floor plan" results, showing no threshold effect (Figure 2A), no distribution along the same line DOR value as the pooled DOR value of each study in the DOR forest diagram, as well as a Cochran-Q = 155.64 (I2= 76.9%,P< 0.001), indicating that the heterogeneity was generated by a nonthreshold effect (Figure 2B).
Summary effect size of T staging:The pooled sensitivity of all the studies had anI² = 91.7%, and the sensitivity was combined with the random effects model, which resulted in a pooled sensitivity of 0.67 (95%CI: 0.65-0.70) (Figure 2C). The pooled specificity of the studies had anI² = 96.7%, and the specificity was combined with the random effects model, which resulted in a pooled specificity of 0.81 (95%CI: 0.80-0.83) (Figure 2D). The pooled positive LR of the studies had anI² = 97.6%, and the positive likelihood ratio was combined with the random effects model, which resulted in a pooled positive LR of 4.13 (95%CI: 2.66-6.41) (Figure 3A). The pooled negative likelihood ratio of the studies had anI² = 91.6%, and the negative LR was combined with the random effects model, which resulted in a pooled negative LR of 0.39 (95%CI: 0.31-0.49) (Figure 3B). The pooled DOC of the studies had anI² = 76.9%, and the DOC value was combined with the random effects model, which resulted in a pooled DOC value of 10.81 (95%CI: 7.33-15.94) (Figure 2B). The area under the fitted ROC curve was 0.829 (Figure 3C).
Table 1 Basic characteristics of studies included
Publication bias of T staging:Deeks' funnel plot asymmetry test was conducted to assess the publication bias of the studies in the meta-analysis, withP= 0.02 as shown in Figure 3D, indicating a significant publication bias in the included literature on the 16-slice CT diagnosis of colorectal cancer T staging.
Heterogeneity of meta-analysis of N staging:There was no "shoulder-arm" distribution in the "ROC floor plan" results, showing no threshold effect (Figure 4A), no distribution along the same line of DOR value as the pooled DOR value of each study in the DOR forest diagram, as well as a Cochran-Q = 28.09 (I2= 75.1%,P< 0.001), indicating that the heterogeneity was generated by a nonthreshold effect. Qualitative details are provided in Figure 4B.
Summary effect size of N staging:The pooled sensitivity of all the studies had anI² = 91.9%, and the sensitivity was combined with the random effects model, which resulted in a pooled sensitivity of 0.54 (95%CI: 0.49-0.59) (Figure 5A). The pooled specificity of the studies had anI² = 92.9%, and the specificity was combined with the random effects model, which resulted in a pooled specificity of 0.74 (95%CI: 0.70-0.77) (Figure 5B). The pooled positive LR of the studies had anI² = 77.8%, and the positive LR was combined with the random effects model, which resulted in a pooled positive likelihood ratio of 1.92 (95%CI: 1.36-2.70) (Figure 5C). The pooled negative LR of the studies had anI² = 78.5%, and the negative LR was combined with the random effects model, which resulted in a pooled negative LR of 0.67 (95%CI: 0.51-0.87) (Figure 5D). The pooled DOC of the studies had anI² = 76.9%, and the DOC value was combined with the random effects model, which resulted in a pooled DOC value of 3.74 (95%CI: 1.76-7.94) (Figure 4B). The area under the fitted ROC curve had an AUC of 0.829 (Figure 6).
Publication bias of N staging:With little literature included (n< 10), the publication bias of the ≥ 16-slice CT diagnosis of colorectal cancer N staging was not assessed.
The staging of colon cancer is mostly performed according to the American Joint Committee on Cancer (AJCC)[26], which distinguishes patients based on the degree of primary tumor invasion (T stage), lymph node status (N stage), and distant spread (M stage). Clinical studies have disclosed that the invasion depth, the presence or absence of lymph node metastasis, and distant metastasis are key factors affecting the clinical prognosis of rectal cancer[27], leading to the conclusion that the application of imaging methods to accurately assess and summarize tumor stage, the surrounding anatomical relationships, and metastasis is of great value for rationally formulating treatment plans and improving clinical prognosis. This study systematically assessed the accuracy of 16-slice SCT in the diagnosis of localized colon cancer.
Table 2 Results of T staging in included studies
Table 3 Results of N staging in included studies
Table 4 Diagnostic results of included studies
Figure 2 Forest plot of meta-analysis of studies using ≥ 16-slice computed tomography for colorectal cancer T staging. A: Receiver operating characteristic plan; B: Forest plot of diagnostic odds ratio; C: Forest plot of sensitivity; D: Forest plot of specificity.
In this study, ≥ 16-slice SCT were shown to have a relatively low sensitivity of only 67% and specificity of 81% for the diagnosis of colon cancer T staging, with the relatively low sensitivity ascribed mainly to the following factors: (1) In this study, the T stages were divided into subgroups and discussed in more detail, with the diagnostic results of T1 and T2 of the colorectal cancer displayed and T4 discussed only by Laoet al[23], with unsatisfactory sensitivity and no bowel preparation applied; (2) Two independent investigators’ diagnostic results were adopted by Rollvénet al[16], with inconsistent judgments, and in most cases, the treatment plans for different colon cancer T stages would not be changed, since most primary tumor resections in patients were conducted when symptoms such as rectal bleeding or intestinal obstruction were already in existence or might occur in the near future[28,29].
Figure 3 Forest plot of meta-analysis of studies using ≥ 16-slice computed tomography for colorectal cancer T staging. A: Positive LR; B: Negative LR; C: Summary receiver operating characteristic curve; D: Deeks' funnel plot.
In this study, ≥ 16-slice SCT were shown to have a relatively low sensitivity of only 54% and specificity of 74% for the diagnosis of colon cancer N staging, although there is little literature on the staging reported. During the process of colon cancer treatment, the different lymph node stages will only affect the need for lymph node resection beyond the surgical margin, which largely depends on the existence of distant metastases and/or the presence of clinically relevant complications, and adjuvant chemotherapy is determined based on the presence of metastatic lymph nodes in the resected specimen, rather than on the suspicion of its existence based on imaging techniques[30,31].
The limitations of this study are: (1) This system was explored by only 11 studies (5 using 16-slice CT, 6 using 64-slice CT, and 1 using the combination of the 16- and 64-slice CT), with the different slices of CT divided into subgroups going undiscussed, thus failing to determine whether there is a difference in the detection effect of different slices on the local stage of colon cancer; (2) This system only explored the diagnostic effects of ≥ 16-slice SCT for colon cancer T staging and N staging, without discussion over the more detailed staging; (3) Of the 11 included studies, 4 are retrospective reviews, where only some of the patients were possibly recommended to have a CT test, indicating a low inclusion probability of the patients with early or advanced stage of colon cancer; and (4) There was a significant publication bias in the studies included in this system.
Figure 4 Pooled effect plot of ≥ 16-slice computed tomography for colorectal cancer N staging. A: Receiver operating characteristic plan; B: Diagnostic odds ratio.
Figure 5 Forest plot of summary effect of ≥ 16-slice computed tomography for colorectal cancer N staging. A: Sensitivity; B: Specificity; C: Positive LR; D: Negative LR.
With the detection of tumors by CT depending largely on the sizes of the tumors, some locally advanced tumors that are confirmed by histopathological tests may be too small to be detected by CT. Thus, sensitivity and specificity are of special importance in the development of screening tests because individuals with the diseases are preferred for recruitment. It was revealed in this study that the sensitivity and specificity of ≥ 16-slice SCT for colon cancer T staging and N staging are acceptable, which is indicative of the good diagnostic value of ≥ 16-slice SCT for local staging of colon cancer. The accuracy of these findings will need to be confirmed by further clinical studies.
We would like to thank all authors of the included primary studies.
Figure 6 Summary receiver operating characteristic curve of ≥ 16-slice computed tomography for colorectal cancer N staging.
Author contributions:Liu D wrote the main manuscript and fully participated in all analyses; Liu D and Sun LM contributed to the study concept and design; Liang JH, Liu XP, and Song L participated in literature search, data extraction, and quality assessment; all authors read and approved the final manuscript.
Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.
PRlSMA 2009 Checklist statement:The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Country/Territory of origin:China
ORClD number:Dan Liu 0000-0002-1228-8318; Lin-Mei Sun 0000-0001-5430-2811; Jing-Hua Liang 0000-0003-2242-2207; Lei Song 0000-0002-4446-8233; Xiao-Pei Liu 0000-0002-7688-2279.
S-Editor:Xing YX
L-Editor:Wang TQ
P-Editor:Xing YX
我们致力于保护作者版权,注重分享,被刊用文章因无法核实真实出处,未能及时与作者取得联系,或有版权异议的,请联系管理员,我们会立即处理! 部分文章是来自各大过期杂志,内容仅供学习参考,不准确地方联系删除处理!